4-Sep-2026 - The Globe and Mail Why Moderna (MRNA) Stock Is Down Today Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker downgraded the company to Sell from Neutral on valuation ...
4-Sep-2026 - Fintel Rothschild & Co downgrades Moderna (MRNA) to sell from neutral Fintel reports that on September 3, 2026, Rothschild & Co downgraded their outlook for Moderna (NASDAQGS:MRNA) from Neutral to Sell. Moderna, Inc. is a biotechnology company based in the United States ...
4-Sep-2026 - Yahoo Finance GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says GSK PLC's (LSE:GSK, NYSE:GSK) experimental mRNA flu vaccine produced data that closely resemble Moderna's own candidate, according to Deutsche Bank. Analyst Emmanuel Papadakis reviewed detailed phase ...
4-Sep-2026 - The Globe and Mail Why Moderna (MRNA) Stock Is Down Today Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker downgraded the company to Sell from Neutral on valuation ...
4-Sep-2026 - Fintel Rothschild & Co downgrades Moderna (MRNA) to sell from neutral Fintel reports that on September 3, 2026, Rothschild & Co downgraded their outlook for Moderna (NASDAQGS:MRNA) from Neutral to Sell. Moderna, Inc. is a biotechnology company based in the United States ...
4-Sep-2026 - Yahoo Finance GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says GSK PLC's (LSE:GSK, NYSE:GSK) experimental mRNA flu vaccine produced data that closely resemble Moderna's own candidate, according to Deutsche Bank. Analyst Emmanuel Papadakis reviewed detailed phase ...
